BATTLE-FL: A Biomarker-Integrated Study in Patients With Advanced Non-Small Cell Lung Cancer Treated in the Front-Line (FL) Setting.
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 21 Jun 2017
At a glance
- Drugs Bevacizumab (Primary) ; Cixutumumab (Primary) ; Pemetrexed (Primary) ; Carboplatin
- Indications Non-small cell lung cancer
- Focus Biomarker; Therapeutic Use
- Acronyms BATTLE-FL
- 14 Jun 2017 Planned primary completion date changed from 1 Jul 2018 to 1 Jul 2019.
- 18 Oct 2016 Planned primary completion date changed from 1 Jul 2017 to 1 Jul 2018.
- 16 Oct 2015 Planned primary completion date changed from 1 Jul 2016 to 1 Jul 2017, as reported by ClinicalTrials.gov.